Surveillance Behavior and Prophylactic Surgery After Predictive Testing for Hereditary Breast/Ovarian Cancer

References

• Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr. 1999;25:59-66.
   Google Scholar
• Miki, Y. Swensen, J. Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66-71.
   Google Scholar
• Wooster, R. Bignell, G. Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789-792.
   Google Scholar
• Bleiker EMA, Hahn DEE, Aaronson NK. Psychosocial issues in cancer genetics. Acta Oncol. 2003;42:276-286.
   Google Scholar
• Levine DA, Gemignani ML. Prophylactic surgery in hereditary breast/ovarian cancer syndrome. Oncology. 2003;17:932-941.
   Google Scholar
• Watson, M. Foster, C. Eeles, R. et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer. 2004;91:1787-1794.
   Google Scholar
• Botkin JR, Smith KR, Croyle RT, et al. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet. 2003;118A:201-209.
   Google Scholar
• Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346:1609-1615.
   Google Scholar
• Tinley ST, Houfek, J. Watson, P. et al. Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet. 2004;125A:5-11.
   Google Scholar
• Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11:1-47.
   Google Scholar
• Scheuer, L. Kauff, N. Robson, M. et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;5:1260-1268.
   Google Scholar
• Schwartz, M. Kaufman, E. Peshkin BN, et al. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol. 2003;21:4034-4041.
   Google Scholar
• Eisinger, F. Geller, G. Burke, W. Holtzman NA. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet. 1999;353:919-920.
   Google Scholar
• Loader, S. Levenkron JC, Rowley PT. Genetic testing for breast-ovarian cancer susceptibility: a regional trial. Genet Test. 1998;2:305-313.
   Google Scholar
• Julian-Reynier CM, Bouchard LJ, Evans DG, et al. Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another. Cancer. 2001;92:959-968.
   Google Scholar
• Leventhal, H. Diefenbach, M. Leventhal E. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognit Ther Res. 1992;16:143-163.
   Google Scholar
• Milne, S. Sheeran, P. Orbell S. Prediction and intervention in health-related behavior: a meta-analytic review of protection motivation theory. J Appl Soc Psychol. 2000;30:106-143.
   Google Scholar
• King ES, Rimer BK, Trock, B. Balshem TB, Engstrom P. How valid are mammography self-reports? Am J Public Health.
   Google Scholar
• Armstrong, K. Calzone, K. Stopfer, J. Fitzgerald, G. Coyne, J. Weber B. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev. 2000;9:1251-1254.
   Google Scholar
• Audrain, J. Schwartz MD, Lerman, C. Hughes, C. Peshkin PN, Biesecker B. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med. 1997;19:370-377.
   Google Scholar
• Cohen, M. First-degree relatives of breast-cancer patients: cognitive perceptions, coping and adherence to breast self-examination. Behav Med. 2002;28:15-22.
   Google Scholar
• McCaul KD, Tulloch HE. Cancer screening decisions. J Natl Cancer Inst Monogr. 1999;25:52-58.
   Google Scholar
• Sermijn, E. Goelen, G. Teugels, E. et al. The impact of probands mediated information dissemination in families with a BRCA1/2 gene mutation. J Med Genet. 2004;41:e23.
   Google Scholar
• Decruyenaere, M. Evers-Kiebooms, G. Welkenhuysen, M. Denayer, L. Claes E. Cognitive representations of breast cancer, emotional distress and preventive health behaviour: a theoretical perspective. Psychooncology. 2000;9:528-536.
   Google Scholar
• Diefenbach MA, Miller SM, Daly MB. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol. 1999;18:532-536.
   Google Scholar
• Lodder, L. Frets PG, Trijsburg RW, et al. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing. Am J Med Genet. 2003;119A:266-272.
   Google Scholar
• Decruyenaere, M. Evers-Kiebooms, G. Denayer, L. et al. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counseling. Eur J Hum Genet. 2000;8:130-136.
   Google Scholar
• Champion VL. Instrument development for health belief model constructs. ANS Adv Nurs Sci. 1984;6:73-85.
   Google Scholar
• European Guidelines for Quality Assurance in Mammography Screening. 3rd ed. Brussels: European Communities, 2001.
   Google Scholar
• Lerman, C. Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat. 1993;28:145-155.
   Google Scholar
• Horowitz MJ, Wilner, N. Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41:209-218.
   Google Scholar
• Evans DGR, Lalloo, F. Shenton, A. Boggis, C. Howell A. Uptake of screening and prevention in women at very high risk of breast cancer. Lancet. 2001;358:889-890.
   Google Scholar
• Meijers-Heijboer EJ, Verhoog LC, Brekelmans CTM, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet. 2000;355:2015-2020.
   Google Scholar
• Patenaude AF, Schneider KA, Kieffer SA, et al. Acceptance of invitations for p53 and BRCA1 predisposition testing: factors influencing potential utilization of cancer genetic testing. Psychooncology. 1996;5:241-250.
   Google Scholar
• Foster, C. Evans DGR, Eeles, R. et al. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer. 2002;8:1209-1216.
   Google Scholar
• Weyler, J. Schrijvers, J. Vandermeeren, I. Vuylsteke de Laps L (eds). Multicenterstudie borstkanker screening Vlaanderen. Rapport van onderzoek uitgevoerd in opdracht van het Ministerie van de Vlaamse Gemeenschap. Brussels, Belgium: Ministry of the Flemish Community, 1997.
   Google Scholar
• Peshkin BN, Schwartz MD, Isaacs, C. Hughes, C. Main, D. Lerman C. Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev. 2002;11:1115-1118.
   Google Scholar
• Kash KM, Holland JC, Osborne MP, Miller DG. Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr. 1995;17:73-79.
   Google Scholar
• Schwartz MD, Taylor ML, Willard KS. Prospective association between distress and mammography utilization among women with a family history of breast cancer. J Behav Med. 2003;26:105-117.
   Google Scholar
• Isaacs, C. Peshkin BN, Schwartz, M. DeMarco TA, Main, D. Lerman C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat. 2002;71:103-112.
   Google Scholar
• Lerman, C. Schwartz MD, Lin TH, Hughes C. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol. 1997;65:414-420.
   Google Scholar
• Claes, E. Evers-Kiebooms, G. Boogaerts, A. Decruyenaere, M. Denayer, L. Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet. 2003;116A:11-19.
   Google Scholar
• Lodder LN, Frets PG, Trijsburg RW, et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat. 2002;73:97-112.
   Google Scholar
• Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst. 1992;84:24-30.
   Google Scholar
• Lerman, C. Hughes, C. Croyle RT, et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med. 2000;31:75-80.
   Google Scholar
• Metcalfe KA, Liede, A. Hoodfar, E. Scott, A. Foulkes WD, Narod SA. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counseling. J Med Genet. 2000;37:866-874.
   Google Scholar